Lectins and coding sequences
Overview
Abstract
Abstract
The present disclosure provides a novel family of C-type lectins from vertebrates. As specifically exemplified, this family of lectins includes a melibiose-specific lectin (XL35) from Xenopus laevis oocytes, and two human lectins, HL-3 and HL-13, specifically expressed in endothelial cells such as blood vessels, stomach, small intestine, heart and tissue and in small intestine, respectively. Amino acid sequences of the lectin proteins are provided herein, together with the nucleotide sequences encoding these proteins.
Assignees with Similar Patents
Referenced by
- University of Maryland At Baltimore (3)
-
| Number |
Title |
Issue Date |
| 7312197 |
Method of modifying glucose activity using polypeptides selectively expressed in fat tissue |
2007/12/25 |
| 7550435 |
Method of modifying glucose activity using polypeptides selectively expressed in fat tissue |
2009/06/23 |
| 8058014 |
Method of diagnosing or predicting disease states in a subject using omentin 1 and omentin 2 |
2011/11/15 |
- theobald therapeutics (1)
-
| Number |
Title |
Issue Date |
| 11813295 |
Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity |
2023/11/14 |
- Quest Diagnostics (1)
-
| Number |
Title |
Issue Date |
| 6635255 |
CASB414:antigen overexpressed in several tumors |
2003/10/21 |
- UNIVERSITY OF GEORGIA, THE (1)
-
| Number |
Title |
Issue Date |
| 6524820 |
Lectins and coding sequences |
2003/02/25 |
- bermudes david (1)
-
| Number |
Title |
Issue Date |
| 12378536 |
Chimeric protein toxins for expression by therapeutic bacteria |
2025/08/05 |
Tech Analysis
| Class |
Subclass |
Type |
Reference Factor |
Citation Factor |
Strength |
Grant time |
Early grant (%) |
|
435
|
252.3
|
Emerging |
Average |
Seminal |
Medium High |
Average |
33.8 |
|
435
|
320.1
|
Emerging |
Average |
Seminal |
Medium High |
Average |
29.4 |
|
435
|
325
|
Emerging |
Novel |
Seminal |
High |
Average |
28.1 |
|
435
|
69.1
|
Emerging |
Average |
Seminal |
Medium High |
Average |
29.0 |
|
536
|
23.1
|
Emerging |
Novel |
Seminal |
High |
Average |
31.8 |
|
536
|
23.5
|
Emerging |
Average |
Seminal |
Medium High |
Average |
27.3 |